<VariationArchive VariationID="17853" VariationName="NM_000041.4(APOE):c.415_435dup (p.Glu139_Gly145dup)" VariationType="Duplication" Accession="VCV000017853" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-02" DateCreated="2019-11-24" MostRecentSubmission="2019-11-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32892" VariationID="17853">
      <GeneList>
        <Gene Symbol="APOE" FullName="apolipoprotein E" GeneID="348" HGNC_ID="HGNC:613" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="44905796" stop="44909393" display_start="44905796" display_stop="44909393" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="45409038" stop="45412649" display_start="45409038" display_stop="45412649" Strand="+" />
          </Location>
          <OMIM>107741</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000041.4(APOE):c.415_435dup (p.Glu139_Gly145dup)</Name>
      <CanonicalSPDI>NC_000019.10:44908706:CGGCGAGGTGCAGGCCATGCTCGGC:CGGCGAGGTGCAGGCCATGCTCGGCGAGGTGCAGGCCATGCTCGGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="44908706" stop="44908707" display_start="44908706" display_stop="44908707" variantLength="21" positionVCF="44908706" referenceAlleleVCF="G" alternateAlleleVCF="GCGGCGAGGTGCAGGCCATGCT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="45411963" stop="45411964" display_start="45411963" display_stop="45411964" variantLength="21" positionVCF="45411963" referenceAlleleVCF="G" alternateAlleleVCF="GCGGCGAGGTGCAGGCCATGCT" />
      </Location>
      <OtherNameList>
        <Name>APOE Leiden</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007084.2" sequenceAccession="NG_007084" sequenceVersion="2" change="g.7930_7950dup">
            <Expression>NG_007084.2:g.7930_7950dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.44908711_44908731dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.44908711_44908731dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.45411968_45411988dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.45411968_45411988dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000041.4" sequenceAccession="NM_000041" sequenceVersion="4" change="c.415_435dup" MANESelect="true">
            <Expression>NM_000041.4:c.415_435dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000032.1" sequenceAccession="NP_000032" sequenceVersion="1" change="p.Glu139_Gly145dup">
            <Expression>NP_000032.1:p.Glu139_Gly145dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001302688.2" sequenceAccession="NM_001302688" sequenceVersion="2" change="c.493_513dup">
            <Expression>NM_001302688.2:c.493_513dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001289617.1" sequenceAccession="NP_001289617" sequenceVersion="1" change="p.Glu165_Gly171dup">
            <Expression>NP_001289617.1:p.Glu165_Gly171dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001302689.2" sequenceAccession="NM_001302689" sequenceVersion="2" change="c.415_435dup">
            <Expression>NM_001302689.2:c.415_435dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001289618.1" sequenceAccession="NP_001289618" sequenceVersion="1" change="p.Glu139_Gly145dup">
            <Expression>NP_001289618.1:p.Glu139_Gly145dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001302690.2" sequenceAccession="NM_001302690" sequenceVersion="2" change="c.415_435dup">
            <Expression>NM_001302690.2:c.415_435dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001289619.1" sequenceAccession="NP_001289619" sequenceVersion="1" change="p.Glu139_Gly145dup">
            <Expression>NP_001289619.1:p.Glu139_Gly145dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001302691.2" sequenceAccession="NM_001302691" sequenceVersion="2" change="c.415_435dup">
            <Expression>NM_001302691.2:c.415_435dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001289620.1" sequenceAccession="NP_001289620" sequenceVersion="1" change="p.Glu139_Gly145dup">
            <Expression>NP_001289620.1:p.Glu139_Gly145dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA127504" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="107741.0006" DB="OMIM" />
        <XRef Type="rs" ID="397514254" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000041.4(APOE):c.415_435dup (p.Glu139_Gly145dup) AND Familial type 3 hyperlipoproteinemia" Accession="RCV000019434" Version="31">
        <ClassifiedConditionList TraitSetID="5895">
          <ClassifiedCondition DB="MedGen" ID="C0020479">Familial type 3 hyperlipoproteinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2004-04-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-11-24" MostRecentSubmission="2019-11-24">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15096402</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2556398</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3721502</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7175379</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5895" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12902" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia type 3</ElementValue>
                <XRef ID="MONDO:0018473" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia type III</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dysbetalipoproteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial dysbetalipoproteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Broad beta disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Remnant removal disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial type 3 hyperlipoproteinemia</ElementValue>
                <XRef ID="398796005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Broad-betalipoproteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Apolipoprotein e, deficiency or defect of</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dysbetalipoproteinemia due to defect in apolipoprotein e-d</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial hyperbeta- and prebetalipoproteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial hypercholesterolemia with hyperlipemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Floating-betalipoproteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipemia with familial hypercholesterolemic xanthomatosis</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6703" />
                <XRef ID="6703" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ES, 2012">
                <ID Source="PubMed">22962670</ID>
                <ID Source="pmc">3431581</ID>
              </Citation>
              <XRef ID="412" DB="Orphanet" />
              <XRef ID="C0020479" DB="MedGen" />
              <XRef ID="MONDO:0018473" DB="MONDO" />
              <XRef Type="MIM" ID="617347" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39724" SubmissionDate="2019-11-22" DateLastUpdated="2019-11-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="107741.0006_HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE3-LEIDEN" title="APOE, 21-BP DUP, CODONS 121-127_HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE3-LEIDEN" />
        <ClinVarAccession Accession="SCV000039724" DateUpdated="2019-11-24" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Havekes et al. (1986) found type III hyperlipoproteinemia (617347) in a dominant pedigree pattern in a family with a variant of E3 that they called E3(Leiden). By isoelectric focusing, the affected persons appeared to be homozygous for normal apoE3, but the variant E3 showed defective binding to LDL receptor, and on sodium dodecyl sulfate polyacrylamide gel electrophoresis showed mobility intermediate to those of normal E3 and normal E2. The mother and 5 of 8 sibs had type III HLP; 4 of the 5 had xanthomatosis. The affected persons were heterozygotes E3/E3(Leiden). Wardell et al. (1989) demonstrated a 7-amino acid insertion that is a tandem repeat of residues 121-127. In a screening of patients with familial dysbetalipoproteinemia, de Knijff et al. (1991) found 5 probands showing heterozygosity for the APOE*3-Leiden allele. Genealogic studies revealed that these probands shared common ancestry in the 17th century. In 1 large kindred spanning 3 generations, 37 additional heterozygotes were detected. Although severity varied, all carriers showed characteristics of dysbetalipoproteinemia such as: (a) elevated levels of cholesterol in VLDL and IDL fractions; (b) elevated ratios of cholesterol levels in these density fractions over total plasma levels of triglycerides; and (c) strongly increased plasma levels of apoE. Multiple linear regression analysis showed that most of the variability in expression of familial dysbetalipoproteinemia in APOE*3-Leiden allele carriers can be explained by age.</Attribute>
              <Citation>
                <ID Source="PubMed">3721502</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2556398</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">15096402</ID>
              </Citation>
              <XRef DB="OMIM" ID="617347" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a discussion of mouse models of atherosclerosis, Breslow (1996) referred to the development of a transgenic mouse carrying the APOE-Leiden mutation. When fed a very high cholesterol diet containing cholic acid, these mice had cholesterol levels of 1,600 to 2,000 mg/dl and developed fatty streak and fibrous plaque lesions.</Attribute>
              <Citation>
                <ID Source="PubMed">7175379</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOE" />
          </GeneList>
          <Name>APOE, 21-BP DUP, CODONS 121-127</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">21-BP DUP, CODONS 121-127</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="107741.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE3-LEIDEN</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

